Panna Sharma on Leveraging Artificial Intelligence To Rescue and Develop Cancer Therapies

Welcome to another episode of The Action and Ambition Podcast! Joining us today is Panna Sharma, President, CEO and, Board Member of Lantern Pharma, Inc. Lantern Pharma is a clinical-stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data, and precision oncology trials. Panna was also the President and CEO of Cancer Genetics, Inc. A provider of genomic and immune-based cancer diagnostics and therapy development services. Tune in to learn more!